Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.62 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | STAT3 | P40763 | 1/20 | 0.53 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.53 |
| ▸ | RELA | Q04206 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17394788 | 0.90 | SLC22A6 (0.62) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL28224425 | 0.87 | PDE4B (0.55) | MEN1KMT2AGAA | |
| SCHEMBL28223820 | 0.84 | ALDH1A1 (0.53) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL3276465 | 0.83 | MEN1 (0.57) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL1491848 | 0.81 | MEN1 (0.68) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL1396833 | 0.81 | MEN1 (0.68) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL6553082 | 0.81 | MEN1 (0.62) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL7433907 | 0.80 | MEN1 (0.66) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL28052189 | 0.80 | MEN1 (0.66) | SLC22A6SLC22A8MEN1RAB9AKMT2A | |
| SCHEMBL16360980 | 0.80 | MEN1 (0.66) | SLC22A6SLC22A8MEN1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112868647-A | Application of perfume compound in preparation of sanitary articles for inhibiting infection of novel coronavirus | 广西壮族自治区中国科学院广西植物研究所 | 2021-06-01 | — | — | CN | claimed |
| CN-115279206-A | Flavor composition | 弗门尼舍有限公司 | 2022-11-01 | — | — | CN | disclosed |
| US-20220127217-A1 | METHODS OF DEPOLYMERIZING LIGNIN | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2022-04-28 | — | — | US | disclosed |
| CN-108135859-B | Packaging method | 罗地亚经营管理公司 | 2021-08-10 | — | — | CN | disclosed |
| CN-112868647-A | Application of perfume compound in preparation of sanitary articles for inhibiting infection of novel coronavirus | 广西壮族自治区中国科学院广西植物研究所 | 2021-06-01 | — | — | CN | disclosed |
| WO-2015119277-A1 | PRODUCTION METHOD FOR 1-(4-HYDROXY-3-METHOXYPHENYL)-1,3-PROPANEDIOL | 国立研究開発法人海洋研究開発機構 | 2015-08-13 | — | — | WO | disclosed |
| US-9060945-B2 | Use of danielone and derivatives thereof in skin care | DSM IP ASSETS B.V. (NL) | 2015-06-23 | — | — | US | disclosed |
| US-20150004108-A1 | USE OF DANIELONE AND DERIVATIVES THEREOF IN SKIN CARE | DSM IP ASSETS B.V. (NL) | 2015-01-01 | — | — | US | disclosed |
| CN-104039301-A | Use of danielone and derivatives thereof in skin care | DSM IP ASSETS BV | 2014-09-10 | — | — | CN | disclosed |
| EP-2616481-A2 | BIOPRODUCTION OF AROMATIC CHEMICALS FROM LIGNIN-DERIVED COMPOUNDS | Aligna Technologies, Inc. (US) | 2013-07-24 | — | — | EP | disclosed |
| WO-2013104526-A1 | USE OF DANIELONE AND DERIVATIVES THEREOF IN SKIN CARE | DSM IP ASSETS B.V. (NL) | 2013-07-18 | — | — | WO | disclosed |
| US-20130143304-A9 | LIGF-TYPE SYSTEMS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. | 2013-06-06 | — | — | US | disclosed |
| US-20120202257-A1 | LIGE-TYPE ENZYMES FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. | 2012-08-09 | — | — | US | disclosed |
| US-20120202272-A1 | LIGE-TYPE SYSTEMS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC | 2012-08-09 | — | — | US | disclosed |
| US-20120202258-A1 | LIGE-TYPE TRANSFORMANTS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. | 2012-08-09 | — | — | US | disclosed |
| US-20120196335-A1 | LIGF-TYPE TRANSFORMANTS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. | 2012-08-02 | — | — | US | disclosed |
| US-20120196353-A1 | LIGF-TYPE SYSTEMS FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | CHATTERJEE RANJINI (US) | 2012-08-02 | — | — | US | disclosed |
| US-20120196334-A1 | LIGF-TYPE ENZYMES FOR BIOCONVERSION OF LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. | 2012-08-02 | — | — | US | disclosed |
| WO-2012036884-A2 | BIOPRODUCTION OF AROMATIC CHEMICALS FROM LIGNIN-DERIVED COMPOUNDS | ALIGNA TECHNOLOGIES, INC. (US) | 2012-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150004108-A1 | USE OF DANIELONE AND DERIVATIVES THEREOF IN SKIN CARE | TYR, MITF, MC1R | SLC22A6 2238/4885SLC22A8 3538/4885MEN1 4325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.